BFRA - Biofrontera AG

NasdaqCM - NasdaqCM Real-time price. Currency in USD
+0.09 (+0.68%)
At close: 10:02AM EDT
Stock chart is not supported by your current browser
Previous close13.26
Bid13.16 x 900
Ask13.90 x 1000
Day's range13.30 - 13.47
52-week range11.25 - 17.98
Avg. volume2,701
Market cap300.043M
PE ratio (TTM)N/A
EPS (TTM)-0.95
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est20.83
Trade prices are not sourced from all markets
  • GlobeNewswire7 days ago

    Biofrontera files lawsuit against W.K.T. Zours, Deutsche Balaton AG and further defendants

    Leverkusen, Germany, June 12, 2018-- Biofrontera AG, an international biopharmaceutical company, today announced that it has filed a complaint in the United States District Court for the Southern District ...

  • GlobeNewswire20 days ago

    Biofrontera Reports First Quarter 2018 Financial Results

    Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reported its financial results for the first quarter ended March 31, 2018 and provided an update on recent operational and clinical developments. “We entered 2018 with a strong presence in the U.S. achieving record revenue increase and successfully completing an initial public offering on the Nasdaq Capital Market. Combined with a preemptive rights offering in Germany, Biofrontera raised €21.6 million in net proceeds that will support our expansion opportunities.

  • GlobeNewswire2 months ago

    Biofrontera Reports Full Year 2017 Financial Results

    Leverkusen, Germany, April 30, 2018--. Biofrontera AG, an international biopharmaceutical company, today reported its consolidated financial results for the full year ended December 31, 2017 and provided ...

  • GlobeNewswire2 months ago

    Biofrontera announces preliminary unaudited sales revenues for the 1st Quarter 2018

    Leverkusen, Germany, April 12, 2018-- Biofrontera AG, the specialist for the treatment of sun-induced skin cancer, today announced preliminary unaudited revenue for the first quarter of fiscal year 2018.. ...